MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
$123,214,000
EPS
$1.08
Unit: Dollar
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Revenue
0
0
0*
0
Research and development
29,497,000
31,454,000
39,811,000*
34,068,000
General and administrative
17,425,000
17,057,000
31,448,000*
18,351,000
Restructuring
0
-
3,747,000*
-172,000
Total operating expenses
46,922,000
48,511,000
75,006,000*
52,247,000
Loss from operations
-46,922,000
-48,511,000
-75,006,000*
-52,247,000
Gain from sale of prv
178,190,000
-
-
-
Interest expense
473,000
473,000
472,000*
473,000
Interest and other income, net
347,000
161,000
1,091,000*
709,000
Accretion of discount on investments, net
693,000
1,229,000
2,260,000*
1,679,000
Earnings (losses) before income taxes
131,835,000
-
-
-
Provision for income taxes
8,621,000
-
-
-
Net income (loss)
123,214,000
-47,594,000
-72,127,000
-50,332,000
Basic EPS
1.09
-0.42
-0.652
-0.45
Diluted EPS
1.08
-0.42
-0.652
-0.45
Basic Average Shares
112,844,880
112,134,059
110,676,404
111,571,136
Diluted Average Shares
114,513,964
112,134,059
110,676,404
111,571,136
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Gain from sale of prv
$178,190,000
Accretion of discount on
investments, net
$693,000
Interest and other
income, net
$347,000
Earnings (losses) before
income taxes
$131,835,000
Loss from operations
-$46,922,000
Interest expense
$473,000
Net income (loss)
$123,214,000
Provision for income taxes
$8,621,000
Total operating
expenses
$46,922,000
Research and development
$29,497,000
General and
administrative
$17,425,000
Buy us a coffee
ROCKET PHARMACEUTICALS, INC. (RCKTW)
ROCKET PHARMACEUTICALS, INC. (RCKTW)